Cilostazol (NCS HealthCare of KY, Inc dba Vangard Labs)
Welcome to the PulseAid listing for the Cilostazol drug offered from NCS HealthCare of KY, Inc dba Vangard Labs. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NCS HealthCare of KY, Inc dba Vangard Labs |
NON-PROPRIETARY NAME: | Cilostazol |
SUBSTANCE NAME: | CILOSTAZOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-03-23 |
END MARKETING DATE: | 0000-00-00 |
Cilostazol HUMAN PRESCRIPTION DRUG Details:
Item Description | Cilostazol from NCS HealthCare of KY, Inc dba Vangard Labs |
LABELER NAME: | NCS HealthCare of KY, Inc dba Vangard Labs |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2012-03-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0615-7713_de2d67e7-bf27-4764-bbc6-aef1db4f7ea2 |
PRODUCT NDC: | 0615-7713 |
APPLICATION NUMBER: | ANDA077027 |
Other CILOSTAZOL Pharmaceutical Manufacturers / Labelers: